Wendy Sol
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation
Papers in
-
- DNA Repair Mechanisms 5
- Renal and related cancers 3
- Angiogenesis and VEGF in Cancer 3
- Pluripotent Stem Cells Research 3
- Oncology 7
- PARP inhibition in cancer therapy 4
- Co-authors
- Sven Rottenberg (7 shared papers)Jos Jonkers (7 shared papers)Piet Borst (6 shared papers)Ton J. Rabelink (12 shared papers)Ariena Kersbergen (5 shared papers)Bernard M. van den Berg (13 shared papers)Gangqi Wang (10 shared papers)Janneke E. Jaspers (2 shared papers)
- Journals
- Materials Today Bio (2 papers)Nephrology Dialysis Transplantation (2 papers)Cancer Research (2 papers)Cancer Discovery (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- NetherlandsSwitzerlandBelgium
In The Last Decade
Wendy Sol
22 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 85
- Oncology 521
- Critical Care and Intensive Care Medicine 77
- Nephrology 84
- Molecular Biology 664
- Cancer Research 101
Countries citing papers authored by Wendy Sol
This map shows the geographic impact of Wendy Sol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Sol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Sol more than expected).
Fields of papers citing papers by Wendy Sol
This network shows the impact of papers produced by Wendy Sol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Sol. The network helps show where Wendy Sol may publish in the future.
Co-authors
The 25 scholars most cited alongside Wendy Sol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 388 | |
| 2 | 2016 | 115 | |
| 3 | 2019 | 86 | |
| 4 | 2017 | 75 | |
| 5 | 2019 | 56 | |
| 6 | 2014 | 53 | |
| 7 | 2018 | 44 | |
| 8 | 2018 | 36 | |
| 9 | 2023 | 26 | |
| 10 | 2022 | 26 | |
| 11 | 2012 | 24 | |
| 12 | 2017 | 20 | |
| 13 | 2019 | 18 | |
| 14 | 2021 | 14 | |
| 15 | 2012 | 13 | |
| 16 | 2020 | 13 | |
| 17 | 2020 | 11 | |
| 18 | 2020 | 10 | |
| 19 | 2024 | 4 | |
| 20 | 2022 | 2 |
About Wendy Sol
Wendy Sol is a scholar working on Molecular Biology, Oncology, Surgery, Nephrology and Critical Care and Intensive Care Medicine, having authored 22 papers that have together received 1.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (5 papers), PARP inhibition in cancer therapy (4 papers), Renal and related cancers (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Pluripotent Stem Cells Research (3 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and Metabolism and Genetic Disorders (2 papers). The work is most often cited by research in Oncology (521 citations), Critical Care and Intensive Care Medicine (77 citations), Nephrology (84 citations), Molecular Biology (664 citations) and Cancer Research (101 citations). Wendy Sol has collaborated with scholars based in Netherlands, Switzerland and Belgium. Frequent co-authors include Sven Rottenberg, Jos Jonkers, Piet Borst, Ton J. Rabelink, Ariena Kersbergen, Bernard M. van den Berg, Gangqi Wang, Janneke E. Jaspers, Serge A.L. Zander and Rinske Drost. Their work appears in journals such as Materials Today Bio, Nephrology Dialysis Transplantation, Cancer Research, Cancer Discovery and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.